USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

USANA Health Sciences addresses challenges, eyes growth through cost management

USANA Health Sciences navigated a challenging operating environment by focusing on cost management, product demand trends, and growth strategies. Despite facing headwinds in China and Southeast Asia, the company remains resilient and poised for opportunities in new markets and acquisitions.

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Barrier Balm awarded by BELLA Magazine SALT LAKE CITY , May 23, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, is proud to announce its Celavive Postbiotic Barrier Balm was recently named on BELLA magazine's 2024 Best in Skincare award list. This elite list features skincare products carefully selected to cater to all skin types and concerns and help transform skincare routines.

USANA Celavive Postbiotic Barrier Balm Named to Best in Skincare List

Stevanato Group SpA

Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?

USNA vs. STVN: Which Stock Should Value Investors Buy Now?

Mike Sessions honored by Utah Business Magazine SALT LAKE CITY , May 15, 2024 /PRNewswire/ -- As a global leader in its industry, it's vital for a company like USANA to maintain a strong human resources department to ensure employees feel safe and taken care of. USANA would like to congratulate its vice president of HR, Mike Sessions on his recent HR Achievement Award from Utah Business Magazine, recognizing the work he has done within USANA's HR team and for making USANA a great place to work.

USANA HR Executive Awarded for Excellence in his Field

SALT LAKE CITY , May 3, 2024 /PRNewswire/ -- In a heartfelt message in the heart of spring, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), shares his insights and support for May's Family Wellness Month, an initiative that highlights the importance of family health and unity. "My family has been my greatest source of strength and inspiration," said Guest.

USANA Executive Chairman Kevin Guest Advocates for Family Wellness in May's Celebratory Month

Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two companies is the best option for those looking for undervalued stocks?

USNA or STVN: Which Is the Better Value Stock Right Now?

USANA Health Sciences (USNA) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.95 per share a year ago.

USANA Health Sciences (USNA) Q1 Earnings and Revenues Top Estimates

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 30, 2024. Key Financial & Operating Results First quarter net sales were $228 million versus $248 million during Q1 2023, and increased 2% sequentially in constant currency. First quarter diluted EPS was $0.86 as compared with $0.95 during Q1 2023. Company reiterates fiscal year 2024 net sales and diluted EPS outlook of $850 million to $920 mil.

USANA Health Sciences Reports First Quarter 2024 Results

Highlighting USANA's ongoing commitment to people, planet, and products SALT LAKE CITY , April 29, 2024 /PRNewswire/ -- As a global leader in health and wellness, USANA is dedicated to doing its part in creating a better, healthier world. And with a commitment to positive business practices, USANA recently released its fourth annual sustainability report.

USANA Releases 2023 Sustainability Report

Receives Platinum Award from Utah Worksite Wellness Council SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, was recently honored with the Platinum Healthy Worksite award from Utah Worksite Wellness Council (UWWC). To find out more about USANA, please visit USANA.com.

USANA Honored with Local Healthy Worksite Award

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2024 results will be released after the close of market on Tuesday, April 30, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and instit.

USANA Schedules First Quarter 2024 Earnings Release and Conference Call

USANA a double winner at the 2024 Korea Medical Healthcare Awards SEOUL, South Korea , April 9, 2024 /PRNewswire/ -- USANA Health Sciences, a global cellular nutrition company, was recently recognized at the prestigious Korea Medical Healthcare Awards in the multivitamin category for the sixth consecutive year and the weight management category for the fourth consecutive year. The 2024 Korea Medical Healthcare Awards celebrates the medical institutions, companies, and organizations who promote and contribute to the overall national health and the development of the health industry in the country.

USANA Cements Itself as a Premier Cellular Nutrition Company in South Korea

SALT LAKE CITY , April 2, 2024 /PRNewswire/ -- As the business world evolves at an unprecedented rate, the need for individuals who possess a robust growth mindset has never been more critical. Recent findings underscore that companies fostering a culture of continuous learning and adaptability outperform their competitors significantly.

Kevin Guest Says This Spring Cultivate a Growth Mindset: The Essential Soft Skill for Business Success in 2024

Bunge Global SA

Conagra Brands

Fidelity MSCI Consumer Staples ETF

Medifast

Invesco S&P 500 Equal Weight Consumer Staples ETF

Molson Coors Brewing

Consumer Staples Select Sector SPDR Fund

The tobacco and household products industries show the best value scores in the sector.

FSTA: Consumer Staples Sector Dashboard For March

7 Ways to Make the Most of Leap Year Day SALT LAKE CITY , Feb. 28, 2024 /PRNewswire/ -- Every four years, we're given with a unique gift—one extra day. Feb. 29, 2024 is Leap Day, a rare occasion that offers an additional 24 hours in the year.

Kevin Guest Says Leap Forward on Leap Day

Donald Cherry named to Utah Business magazine's 40 Under 40 SALT LAKE CITY , Feb. 22, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. applauds Donald Cherry, executive director of corporate sustainability and DEI, for being named a 40 Under 40 award winner by Utah Business magazine. To find out more about USANA, please visit USANA.com.

USANA Sustainability and DEI Executive Director Awarded in Utah

USANA Health Sciences, Inc. (USNA) Q4 2023 Earnings Call Transcript

USANA Health Sciences (USNA) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.66 per share a year ago.

USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended December 30, 2023. Key Financial Results & Guidance Fourth quarter net sales were $221 million versus $228 million during Q4 2022 and $213 million during Q3 2023. Fourth quarter diluted EPS was $0.87 as compared with $0.66 during Q4 2022. Fiscal year 2023 net sales were $921 million as compared with $999 million during fiscal year 20.

USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2023 Results

Cites 3 Benefits of In-Person Contact SALT LAKE CITY , Feb. 1, 2024 /PRNewswire/ -- February's International Friendship Month is a time for people everywhere to strengthen personal connections in an age where digital communication dominates. "There's nothing more important that relationships," said Kevin Guest, executive chairman at USANA Health Sciences and bestselling author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony.

Kevin Guest Calls on All to Connect during February Month of Friendship

Prestigious validation added for USANA product quality and safety SALT LAKE CITY , Jan. 25, 2024 /PRNewswire/ -- Quality is at the core of everything USANA does, and this drive for excellence is especially apparent in the way the company develops and manufactures safe and effective products. USANA recently added to its long list of third-party validations by earning a Global Food Safety Initiative (GFSI) certification of its foods manufacturing facility through the Safe Quality Foods (SQF) program.

USANA Manufacturing Facility Receives Coveted GFSI Certification from SQF

SALT LAKE CITY , Jan. 23, 2024 /PRNewswire/ -- After a 20-year sponsorship, the USANA Amphitheatre will sport a new name. This change allows USANA Health Sciences, Inc., to focus on supporting other vital community-building projects.

USANA to Continue Investing in Local Community after Decades-Long Amphitheatre Sponsorship Ends

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and fiscal year 2023 results will be released after the close of market on Tuesday, February 6, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with.

USANA Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Calls Out Digital Disconnection Paradox SALT LAKE CITY , Jan. 3, 2024 /PRNewswire/ -- In what some call the era of digital disconnection, 2024 should be the year of human connection to fight loneliness and anxiety, according to one health sciences leader. "In this increasingly digital era, the paradox of disconnection in a connected world is more real than ever," said Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA).

Kevin Guest Names 2024 the Year of Connection

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that it will host investor meetings and a fireside chat presentation at the ICR Conference in Orlando, FL on January 8-9, 2024. Doug Hekking, Chief Financial Officer, will be participating in the fireside chat, scheduled to begin at 10:30 AM ET on January 8, 2024. A live audio webcast of.

USANA Health Sciences to Participate in the 2024 ICR Conference

More than 4,300 bags of food distributed to local schools SALT LAKE CITY , Dec. 20, 2023 /PRNewswire/ -- The holiday season is a time of joy, but it can also be stressful for children who rely on in-school meals as their main food source. With schools going on holiday break, USANA Kids Eat has led a food pack to help keep families fed through the end of the year.

News for USANA Health Sciences Stock (USNA)